Cite Filings / KPTI / 0000919574-22-007017
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13G

Amended Statement of Ownership

Karyopharm Therapeutics Inc. · Filed 2022-12-08 · Acc 0000919574-22-007017

Documents 1

  • SC 13G Amended Statement of Ownership , d9881732_13g.htm

Around this filing

  • 2023-01-20 SC 13G Amended Statement of Ownership
  • 2022-12-08 D Notice of Sales of Unregistered Securities
  • 2022-12-08 SC 13G Amended Statement of Ownership
  • 2022-12-06 4 President and CEO sold 3,490 shares at $5.17 ($18,043)
  • 2022-12-05 8-K Material agreement · Unregistered share sale · Other events
  • 2022-12-02 8-K Bylaws or fiscal year change
  • 2022-05-09 SC 13G Amended Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · RA Capital Management, L.P. 9.9%
  2. 2026-11-13 SCHEDULE 13G/A · Affinity Asset Advisors, LLC 6.5%
Loading d9881732_13g.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…